BRD4 and cancer: The key oncogenic drivers of tumor cells are regulated by SEs, which can confer disproportionate sensitivity to BRD4 coactivator loss and cause selective inhibition of transcription.21 This functional characteristic of cancer cell SEs may be used to identify key oncogenes and develop target drugs.22,68,69